APP and Alzheimer disease: Yao and co-workers has documented elevated level of PRDX2 in cerebral cortex of patients with AD and in transgenic mice expressing amyloid β binding alcohol dehydrogenase (ABAD) and a mutated form of the amyloid precursor protein (APP).